SNIPP study - A investigator initiated phase II study of Sunitinib in patients with recurrent paraganglioma/pheochromocytoma
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Sunitinib (Primary)
- Indications Paraganglioma; Phaeochromocytoma
- Focus Therapeutic Use
- Acronyms SNIPP
- 03 Apr 2017 Status changed from recruiting to completed.
- 21 Jun 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017.
- 21 Jun 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History